Amgen Inc’s experimental obesity drug demonstrated promising durability trends in an early trial, paving the way for a larger mid-stage study early next year, company officials said ahead of a data presentation on Saturday.
- Categories:
- FISM News
Russia has rejected a price cap placed on their oil by Ukraine’s allies and threatened to stop oil exports to all countries that endorse the oil cap.
Last week, Sen. Josh Hawley (R-Mo.) released a series of documents that he said show the Department of Homeland Security’s long-maligned Disinformation Governance Board ran deeper than Secretary Alejandro Mayorkas stated during testimony to the Senate over the summer.